MoneyWorks4Me

The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 859.57 millions.The Net Profit of the company registered a slight decline of -0.64% to Rs. 670.56  millions from Rs. 674.87 millions.The company reported a degrowth in operating Profit to 747.97 millions from 760.26 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 859.57 853.49 0.71 859.57 853.49 0.71 3654.69 3115.29 17.31
Other Income 538.76 512.49 5.13 538.76 512.49 5.13 588.09 98.08 499.60
PBIDT 747.97 760.26 -1.62 747.97 760.26 -1.62 1639.95 846.96 93.63
Interest 0.22 0.35 -37.14 0.22 0.35 -37.14 1.57 1.35 16.30
PBDT 747.75 759.91 -1.60 747.75 759.91 -1.60 1448.90 845.61 71.34
Depreciation 26.19 25.07 4.47 26.19 25.07 4.47 108.98 102.83 5.98
PBT 721.56 734.84 -1.81 721.56 734.84 -1.81 1339.92 742.78 80.39
TAX 51.00 59.97 -14.96 51.00 59.97 -14.96 258.69 187.51 37.96
Deferred Tax 1.54 -0.68 -326.47 1.54 -0.68 -326.47 -10.82 4.97 -317.71
PAT 670.56 674.87 -0.64 670.56 674.87 -0.64 1081.23 555.27 94.72
Equity 223.65 223.65 0.00 223.65 223.65 0.00 223.65 223.65 0.00
PBIDTM(%) 87.02 89.08 -2.31 87.02 89.08 -2.31 44.87 27.19 65.05
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..